Skip to main content
. 2018 May 9;9:1053. doi: 10.3389/fimmu.2018.01053

Figure 7.

Figure 7

Exogenous G-CSF enhanced B6.Sle2c2 dendritic cells functions. (A) Differential gene expression in bone marrow-derived DCs (BMDCs) differentiated from B6 and B6.Sle2c2 mice treated with G-CSF (N = 3). (B) CD40 protein expression in unstimulated and LPS-stimulated BMDCs from G-CSF-treated B6 and B6.Sle2c2 mice. (C) CD154 protein expression on OT-II T cells cocultured with BMDCs from G-CSF treted B6 and B6.Sle2c2 mice, with or without OVA peptide for 72 h (N = 4 per group for (B,C), *p < 0.05, **p < 0.01).